Essa Pharma (EPIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,742 | -35,103 | -28,779 | -19,953 | -9,098 |
| Depreciation Amortization | 30 | 122 | 91 | 61 | 30 |
| Accounts receivable | -8 | 483 | 470 | 476 | 504 |
| Other Working Capital | 932 | -780 | 2,175 | 1,407 | 659 |
| Other Operating Activity | 1,411 | 7,280 | 5,522 | 3,803 | 2,085 |
| Operating Cash Flow | $-4,377 | $-27,999 | $-20,522 | $-14,205 | $-5,820 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1,494 | -53,053 | -49,706 | -37,626 | -11,000 |
| Investing Cash Flow | $-1,494 | $-53,053 | $-49,706 | $-37,626 | $-11,000 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 320 | 320 | 320 | 104 |
| Common Stock Repurchased | 50 | 67 | 67 | 27 | 27 |
| Other Financing Activity | -35 | -134 | -99 | -65 | -32 |
| Financing Cash Flow | $16 | $253 | $287 | $282 | $99 |
| Exchange Rate Effect | 0 | 51 | -17 | -41 | -47 |
| Beginning Cash Position | 57,077 | 137,825 | 137,825 | 137,825 | 137,825 |
| End Cash Position | 51,221 | 57,077 | 67,868 | 86,236 | 121,058 |
| Net Cash Flow | $-5,856 | $-80,749 | $-69,957 | $-51,589 | $-16,767 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,377 | -27,999 | -20,522 | -14,205 | -5,820 |
| Free Cash Flow | -4,377 | -27,999 | -20,522 | -14,205 | -5,820 |